OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-10-31-accounts

Company number: 04620455 Registered Charity: 1099537

European Society for Clinical Virology (Limited by guarantee) Report and Financial Statements for the year ended 31 October 2025

17/07/2026 Page 1 of 10

European Society for Clinical Virology (Limited by Guarantee)

Members of Executive - Company Directors (November 1[st] 2024 - October 31[st] 2025)

Prof. Dr. Pamela Vallely (President) Prof Dr. Mariet C.W. Feltkamp (Past President) Prof. Dr. Annelies Riezebos-Brilman(Vice President) Prof. Dr. Maria São José Alexandre Nascimento (Vice President) Prof. Dr. Catherine Moore (General Secretary) Prof. Dr. Xavier López-Labrador (Communication Officer) Prof. Dr. George Sourvinos (Treasurer) Prof. Dr. Heli Harvala (Meetings Secretary)

Company Secretary

Ester Zoroa, Kenes Group, KAM

Page 2 of 10

European Society for Clinical Virology (Limited by Guarantee)

European Society for Clinical Virology (ESCV) details

Registered Office Charles Darwin House 12 Roger Street London Company limited by guarantee N° 04620455 Registered as a Charity in England N° 1099537

Inland Revenue reference: 610 94961 19846 A 01

Page 3 of 10

European Society for Clinical Virology (Limited by Guarantee)

Directors’ Report

The European Society for Clinical Virology (ESCV) is a Company Limited by Guarantee, first incorporated in 2003. In accordance with the Society’s Memorandum of Association, each Company Member undertakes to contribute such amount as may be required, not exceeding £1, to the Company’s assets if it should be wound up while he or she is a Company Member or within one year after he or she ceases to be so.

The Society is registered as a Charity, the Company Directors being the Charity’s Trustees.

The Company Directors acting collectively are the Society’s Executive.

The Executive hereby submits its report and financial statements for the year ending October 31[st] , 2025.

Organization and Objectives

According to the articles, the Society is administered by the Executive, made up of minimum three and maximum ten Company Directors/Charity Trustees. Currently the Executive numbers eight Directors.

The ESCV has appointed a professional secretariat to handle administrative matters. This secretariat is Kenes Group, Rue François-Versonnex 7, 1207 Geneva, Switzerland.

In accordance with Article 4 the Executive admits as ‘ESCV Members’ such persons and subjects them to such rights and obligations as it thinks fit. Such ‘ESCV Members’ are not Company Members for the purposes of the Articles and are not entitled to vote on any matter save where expressly provided in the Articles.

ESCV members of different European and other countries are represented by councilors, elected by each country’s members according to procedures described in the Articles. The councilors acting collectively are the Council. The Council elects the Company Directors/Charity Trustees according to procedures described in the Articles. The Society’s objectives are to promote public health and to advance public education, in particular medical education, by:

Reserves Policy

The Executive has the policy to maintain sufficient funds to allow the Society to meet its objectives and obligations on a long-term basis, and to provide a measure of investment income. It is the objective of the Society to utilize fully each year’s net income for its charitable activities.

Page 4 of 10

European Society for Clinical Virology (Limited by Guarantee)

Review of Activities in 2024/2025

Scientific Meetings

Awards given at the 27[th ] Annual Conference of the European Society for Clinical Virology 2025 (Thessaloniki)

Travel grants and fellowships given

Training grants

Business Meetings held

Page 5 of 10

European Society for Clinical Virology (Limited by Guarantee)

Future Scientific Meetings planned

Signed on behalf of the Executive (Company Directors),

Prof. Heli Harvala Company President

Page 6 of 10

European Society for Clinical Virology (Limited by Guarantee)

Statement of financial activities (incorporating the income and expenditure account) Year ended 31 0ctober 2025

Page 7 of 10

European Society for Clinical Virology (Limited by Guarantee)

Page 8 of 10

European Society for Clinical Virology (Limited by Guarantee)

Audit Exemption

ii. preparing accounts which give a true and fair view of the state of affairs of the company as at the end of the financial year, and of its profit or loss for the financial year, in accordance with the requirements of section 393, and which otherwise comply with the requirements of the Companies Act relating to accounts, so far as applicable to the company.

(d) These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime.

Approved by Executive on 16 of May 2026 and signed on its behalf by Prof. Heli Harvala (Company President).

Prof. Heli Harvala Company President

Page 9 of 10

European Society for Clinical Virology (Limited by Guarantee)

This page is left blank intentionally (last page)

Page 10 of 10

EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON

Balance sheet accounts as at October 31, 2025

Notes
ASSETS
Bank account
4
Debtor ECCI
Accounts receivable
LIABILITIES
Accounts payable
GENERAL RESERVES
General reserves brought forward
Result of the year
Foreign exchange conversion		 2025
EUR
31’689
9’998
13’284
54’971
1’212
1’212
32’758
21’001
-
53’759
54’971		 2025
GBP
0.87977
27’879
8’796
11’687
48’362
1’066
1’066
27’330
18’476
1’490
47’296
48’362		 2024
EUR
26’529
6’392
-
32’921
163
163
174’036
-141’278
-
32’758
32’921		 2024
GBP
0.83430
22’133
5’333
-
27’466
136
136
151’823
-117’868
-6’625
27’330
27’466

Digitally signed by Heli Harvala Heli DN: cn=Heli Harvala, c=FI, email=heli.harvala@utu.fi Harvala Date: 2026.05.16 21:36:05+03'00'

Authorized signature

Authorized signature

Date _______

The notes to the accounts form part of these financial statements

Page 2

EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON Income & Expenses accounts from 1 November 2024 to 31 October 2025

Notes
INCOMES
Membership fees
Sponsorship
Congress income
5
EXPENSES
Travel grants
Awards
Workshop expenses
Project expenses
Journal expenses
Administrative expenses
Bank charges
Extraordinary expenses
6
Net gain/loss of the year		 2025
2025
EUR
GBP
0.87977
18’186
15’999
6’000
5’279
46’137
40’590
70’323
61’868
13’879
12’210
6’017
5’294
377
332
-
-
1’105
972
26’311
23’147
1’633
1’437
-
-
49’322
43’392
21’001
18’476		 2024
2024
EUR
GBP
0.83430
24’490
20’432
10’500
8’760
37’669
31’427
72’659
60’619
51’546
43’005
10’500
8’760
89’340
74’536
24’342
20’309
1’755
1’464
27’640
23’060
3’814
3’182
5’000
4’171
213’937
178’487
-141’278
-117’868

The notes to the accounts form part of these financial statements Page 3

CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examinerfs Report Report to the trusteesl members of European Society for Clinical Wirology On accounts for the year ended 31" October 2025 Charity no (if any 1099537 Set out on pag8S I report to the trustees on my examination of the accounts of the above charity ('the Trust") for the year ended 3111012025. Responslbllltles and As the charity trustees of the Trust, you are responsible for the preparation basis of report of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act.). I report in respect of my examination of the Trust's accounts Carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by th8 Charity Commission under section 14515)(bl of the Act. I have completed my examinalion. l ¢onfimi that no material matters have come to my attention (other than that dis¢losed below ") in connection with the examination which giv8s me cause to believe that in, any mat8ri81 respect.. accounting records were not kept In ac¢ordanc8 With s8Ction 130 of the Act or the accounts do not accord with th8 accounting records Independent examinerfs statement I have no COn￿rn$ and have come across no other matters in connection with the examination to which attention should be drawn in order to enable proper understanding of the accounts to be reached. 8 d818t8 th8 WO s in the brack8ts if they do not apply. Slgned: Date: Name: Relevant professional qualificatlon(sl or body (if any): C.H. G•urt• ¥•n K*￿¢1 Clinical viroloyist Department ¢fViroscienrAI Erasmus MC Rovierdam Address: IER October 2018

Section B Disclosure Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts.. directions and guidance for examiners). Give here brief details of any items that the examiner wishes to disclose. IER October 2018

CHARITY COMMISSION FOR ENGLAND AND WALES Independent examinerfs report on the accounts Section A Independent Examiner's Report Report to the trusteesl members of European Society for Clinical Virology On accounts for the year anded 3151 Octobèr 2025 Charlty no (if any 1099537 Set out on pages I report to the trustees on rny examination of the accounts of the above charity ('Ihe Trust") for the year ended 3111012026. Re8pon$lbllitles and As the charity trustees of the Trust, you are responsible for the preparation baslg of report of the accounts in accordan￿ with the requirements of the Charities Act 2011 (°the Act,). I report in respect of my examination of the Trust's accounts carried out under seclion 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145151{b) of the Act. I have completed my examination. I confimi that no matenal matters have come to my att8ntion {other than that disclosed below ') in connection with the examination which gives me cause to believe that in, any material respect- accounting records were not kept in accordance with section 130 of the Act or the accounts do not accord with the accounting records Indep•ndant 6xamlnor'8 statsmont I have no concems and have come across no other matters in connection with the examination to which attention should be drawn in order to enab18 proper un nding of the accounts to be reached. Ple8S to the words in the br8ckgts if Ihey do not apply. A2.05. £02 Signed: Dats: Name: 5E7f(]c/D /r*/ Relevant profosslonal qualification{sl or body {rfany): /0 fC£w, Address: IER Octobor 2018

Section 8 Disclosure Only complete ifthe examiner needs to highlight matters of concem (see CC32, Independent examination of charty accounts: directions and guidance for examiners). Give here bri8f datalls of any items that th? èxamlner wlshes to dlsclo80. IER October 2018